| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales > Are You Selling At The Right Level |
|
Useful Advices - Are You Selling At The Right Level
One of the common mistakes salespeople make is they fail to recognize at what level they According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product should be selling their products or services. There are 5 possible sales levels where ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in you can direct your energy, time and talent in the sales process. They are selling at: lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. he product/service level. This is where the salesperson focuses primarily on the price here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe or features of the product or service and define their product as a commodity. The typi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro cal reaction in this phase is to lower price due to a prospect’s price resistance or com ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc etitive pressure. The transaction level. This is where the salesperson sees the sales easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi process in traditional terms – prospecting, the presentation, overcoming objections, clo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically sing the sale. In most cases this approach still tends to focus on the process rather th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n the customer. The solution level. This is where the salesperson brings a solution to ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the prospect/customer for his/her specific problem/need. Although this is better than ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a selling at the transaction level it still focuses on the relationship between the custom dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod r’s needs and the features/benefits of the product/service. The relationship level. Now cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin we are getting more long-term customer focused. Selling at this level requires patience tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen , research, knowledge of the customer’s short and long term agendas, time, effort and a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel illingness to walk away from those sales where there is not a clear win/win/win outcome. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust The stakeholder or shared fate level. Very few salespeople sell at this level. This y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products is where, if your customer loses in any way either directly or indirectly related to you . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de product or service, you lose also.
If you are losing sales ask yourself a simple que elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip stion, Am I selling at the right level with this prospect? If not, where should you be tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Are Your Cleaning Company Workers Employees or Subcontractors? Outsourcing HR - Labor Management
|